ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CSL CSL Limited

273.06
-5.50 (-1.97%)
Apr 26 2024 - Closed
Delayed by 20 minutes

CSL Financial Summary

The current CSL market cap is 131.92B. The company's latest EPS is USD 4.5413 and P/E is 60.13.

Year End June 29 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 8.51B9.1B10.27B10.49B13.17B
Operating Income 2.52B2.72B3.13B2.93B3.07B
Net Income 1.92B2.1B2.38B2.25B2.19B
Year End June 29 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 12.31B15.62B18.16B28.35B36.23B
Total Liabilities 7.06B9.09B9.78B13.77B18.41B
Total Equity 5.25B6.53B8.38B14.58B17.83B

Cash Flow

Year End June 29 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 1.64B2.49B3.62B2.63B2.6B
Investing -1.29B-1.37B-1.67B-1.64B-11.84B
Financing -491.5M-642.7M-1.4B7.68B456M
Market Cap 131.92B
Price to Earnings Ratio 60.13
Price to Sales Ratio 10.01
Price to Cash Ratio 85.22
Price to Book Ratio 7.4
Dividend Yield -

Share Statistics

Shares Outstanding 483.12M
Average Volume (1 week) 849.59k
Average Volume (1 Month) 616.61k
52 Week Change -10.47%
52 Week High 380.01
52 Week Low 152.00
Spread (Intraday) 0.51 (0.19%)

Company Info

Company Name CSL Limited
Address 45 poplar road
melbourne, victoria 3052
Website https://www.csl.com.au
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock